<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="b078dae2-664d-4144-847a-3b9d9b557402"><labelDrug name="Micardis HCT"><Normalization><mmtx cui="C0939381" preferredWord="Micardis-HCT" semType="phsu, orch"/></Normalization></labelDrug><generic name="telmisartan and hydrochlorothiazide"/><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1" text="Drug Label for drug brand Micardis HCT, containing telmisartan and hydrochlorothiazide." type="negative"><entity charOffset="51:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="67:86" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="26:38" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.2" text="micardis hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939381" phraseText="Drug Label for drug brand Micardis HCT," preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.3" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Micardis HCT," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.1.e.2"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7" text="MICARDIS HCT tablets are contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan, hydrochlorothiazide, or any other component of this product (see ADVERSE REACTIONS )." type="negative"><entity charOffset="0:12" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.0" text="micardis hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939381" phraseText="MICARDIS HCT tablets" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="131:150" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="118:129" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.2" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="to telmisartan," preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.7.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.8" text="Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs." type="negative"><entity charOffset="131:142" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.8.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.8.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.8.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.8.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9" lineNumber="23" text="Do not co-administer aliskiren with MICARDIS HCT in patients with diabetes (see PRECAUTIONS, Drug Interactions )." type="regular"><entity charOffset="0:20" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="36:48" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.2" text="MICARDIS HCT" type="Drug"><Normalization><mmtx cui="C0939381" phraseText="aliskiren with MICARDIS HCT" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MICARDIS HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="66:74" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.4" ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.9.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="198:221" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="168:179" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.2" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.18.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.28" text="In rats, maternally toxic (reduction in body weight gain and food consumption) telmisartan doses of 15 mg/kg/day (about 1.9 times the MRHD on a mg/m2 basis), administered during late gestation and lactation, were observed to produce adverse effects in neonates, including reduced viability, low birth weight, delayed maturation, decreased weight gain. " type="negative"><entity charOffset="79:90" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.28.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="telmisartan doses of 15 mg/kg/day" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="150:155" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.28.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.28.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.28.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.30" text="The no observed effect doses for developmental toxicity in rats and rabbits, 5 and 15 mg/kg/day, respectively, are about 0.64 and 3.7 times, on a mg/m2 basis, the maximum recommended human dose of telmisartan (80 mg/day)." type="negative"><entity charOffset="152:157" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.30.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="197:208" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.30.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.30.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.30.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35" text="Initiation of antihypertensive therapy in patients whose renin-angiotensin system are activated such as patients who are intravascular volume- or sodium-depleted, e.g., in patients treated vigorously with diuretics, should only be approached cautiously. " type="negative"><entity charOffset="146:152" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="sodium-depleted," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="205:214" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="vigorously with diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:74" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="whose renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="14:30" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.3" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="Initiation of antihypertensive therapy" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.35.e.2"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36" text="These conditions should be corrected prior to administration of Micardis HCT (telmisartan and hydrochlorothiazide) tablets. " type="negative"><entity charOffset="94:113" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="corrected prior to administration of Micardis HCT (telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="64:76" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.2" text="micardis hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939381" phraseText="corrected prior to administration of Micardis HCT (telmisartan" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.36.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44" lineNumber="47" text="Lithium Interaction : Lithium generally should not be given with thiazides (see PRECAUTIONS, Drug Interactions, Hydrochlorothiazide, Lithium )." type="regular"><entity charOffset="47:59" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.1" text="not be given" type="Caution_Interaction"/><entity charOffset="22:29" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.2" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="65:74" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.3" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.44.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.45" text="Acute Myopia and Secondary Angle-Closure Glaucoma: Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="74:85" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.45.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="a sulfonamide," preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="51:70" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.45.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.45.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.45.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.53" text="Telmisartan and Hydrochlorothiazide" type="negative"><entity charOffset="16:35" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.53.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.53.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="Telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.53.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.53.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.54" text="In controlled trials using the telmisartan/hydrochlorothiazide combination treatment, no patient administered 40/12.5 mg, 80/12.5 mg or 80/25 mg had a decrease in potassium 1.4 mEq/L, and no patient experienced hyperkalemia. " type="negative"><entity charOffset="31:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.54.e.0" text="telmisartan/hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0939233" phraseText="the telmisartan/hydrochlorothiazide combination treatment," preferredWord="Hydrochlorothiazide / telmisartan" semType="phsu, orch"/><RxNorm RxCui="284636"/></Normalization></entity><entity charOffset="163:172" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.54.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="a decrease in potassium 1.4 mEq/L," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.54.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.54.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56" text="The absence of significant changes in serum potassium levels may be due to the opposing mechanisms of action of telmisartan and hydrochlorothiazide on potassium excretion on the kidney." type="negative"><entity charOffset="44:53" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="in serum potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="128:147" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide on potassium excretion" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="112:123" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.2" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="be due to the opposing mechanisms of action of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="151:160" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="hydrochlorothiazide on potassium excretion" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.3"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.56.e.3"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.58" text="Periodic determinations of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. " type="negative"><entity charOffset="33:45" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.58.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="Periodic determinations of serum electrolytes to" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="65:76" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.58.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="possible electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.58.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.58.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.59" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: hyponatremia, hypochloremic alkalosis, and hypokalemia. " type="negative"><entity charOffset="23:31" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.59.e.0" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="90:101" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.59.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.59.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.59.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69" lineNumber="69" text="In diabetic patients dosage adjustments of insulin or oral hypoglycemic agents may be required. " type="irregular"><entity charOffset="21:39" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.1" text="dosage adjustments" type="Caution_Interaction"/><entity charOffset="3:20" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.2" text="diabetic patients" type="SPAN"/><entity charOffset="43:50" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.3" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="54:78" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.4" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.1"><relations><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.4"/></relation><relation type="hasObject"><labelDrug text="Micardis HCT"/><normalization><mmtx><preferredWord>Micardis-HCT</preferredWord><phraseText>aliskiren with MICARDIS HCT</phraseText><cuiCode>C0939381</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.69.e.4"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.75" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="31:38" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.75.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.75.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.75.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.75.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.76" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="63:70" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.76.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="slight elevation of serum calcium" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.76.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.76.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.76.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83" text="Micardis HCT (telmisartan and hydrochlorothiazide) tablets should therefore be used with caution in these patients." type="negative"><entity charOffset="0:12" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.0" text="micardis hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939381" phraseText="Micardis HCT (telmisartan" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="30:49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="14:25" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.2" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="Micardis HCT (telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.83.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.85" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="53:64" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.85.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.85.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.85.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.85.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86" text="In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. " type="negative"><entity charOffset="73:84" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="174:214" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.1" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="219:251" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.2" text="angiotensin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor antagonists" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.3" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.3"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.86.e.2"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.88" text="In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen were observed. " type="negative"><entity charOffset="132:136" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.88.e.0" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="blood urea nitrogen" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><entity charOffset="14:28" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.88.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.88.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.88.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.89" text="There has been no long-term use of telmisartan in patients with unilateral or bilateral renal artery stenosis but an effect similar to that seen with ACE inhibitors should be anticipated." type="negative"><entity charOffset="150:164" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.89.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="seen with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="35:46" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.89.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="no long-term use of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.89.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.89.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93" text="Dual Blockade of the Renin-angiotensin-aldosterone System" type="negative"><entity charOffset="27:38" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-angiotensin-aldosterone System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="39:50" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="Dual Blockade of the Renin-angiotensin-aldosterone System" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="5:13" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.2" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-angiotensin-aldosterone System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.93.e.1"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.94" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function (including acute renal failure) have been reported. " type="negative"><entity charOffset="53:64" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.94.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.94.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.94.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.94.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95" lineNumber="91" text="Dual blockade of the renin-angiotensin-aldosterone system (e.g., by adding an ACE-inhibitor to an angiotensin II receptor antagonist) should include close monitoring of renal function." type="regular"><entity charOffset="155:165" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.1" text="monitoring" type="Caution_Interaction"/><entity charOffset="78:91" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.2" text="ACE-inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="an ACE-inhibitor to an angiotensin II receptor antagonist" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="836"/></Normalization></entity><entity charOffset="98:132" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.3" text="angiotensin II receptor antagonist" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="an ACE-inhibitor to an angiotensin II receptor antagonist" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.95.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.96" text="The ONTARGET trial enrolled 25,620 patients 55 years old with atherosclerotic disease or diabetes with end-organ damage, randomized them to telmisartan only, ramipril only, or the combination, and followed them for a median of 56 months. " type="negative"><entity charOffset="140:151" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.96.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="them to telmisartan only," preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="158:166" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.96.e.1" text="ramipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0072973" phraseText="ramipril only," preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.96.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.96.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97" lineNumber="92" text="Patients receiving the combination of telmisartan and ramipril did not obtain any additional benefit on the composite endpoint of cardiovascular death, myocardial infarction, stroke and heart failure hospitalization compared to monotherapy, but experienced an increased incidence of clinically important renal dysfunction (e.g., acute renal failure) compared with groups receiving telmisartan alone or ramipril alone." type="regular"><entity charOffset="304:321" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.1" text="renal dysfunction" type="Specific_Interaction"/><entity charOffset="38:49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="the combination of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="54:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.3" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="329:348" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.5" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.5"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.97.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98" lineNumber="93" text="Co-administration of telmisartan and ramipril increases the exposure to both ramipril and ramiprilat by a factor of about 2 (see PRECAUTIONS, Drug Interactions )." type="regular"><entity charOffset="46:68" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.1" text="increases the exposure" type="Increase_Interaction"/><entity charOffset="77:85" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.2" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="the exposure to both ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="21:32" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.3" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="Co-administration of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.98.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99" lineNumber="94" text="Concomitant use of telmisartan and ramipril is not recommended." type="regular"><entity charOffset="47:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.1" text="not recommended" type="Caution_Interaction"/><entity charOffset="19:30" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="Concomitant use of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="35:43" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.3" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.99.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104" text="Symptomatic Hypotension : A patient receiving Micardis HCT (telmisartan and hydrochlorothiazide) tablets should be cautioned that lightheadedness can occur, especially during the first days of therapy, and that it should be reported to the prescribing physician. " type="negative"><entity charOffset="76:95" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="46:58" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.1" text="micardis hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939381" phraseText="A patient receiving Micardis HCT (telmisartan" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="60:71" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.2" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="A patient receiving Micardis HCT (telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.104.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107" lineNumber="101" text="Potassium Supplements : A patient receiving MICARDIS HCT tablets should be told not to use potassium supplements or salt substitutes that contain potassium without consulting the prescribing physician." type="regular"><entity charOffset="80:90" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.1" text="not to use" type="Caution_Interaction"/><entity charOffset="116:155" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.2" text="salt substitutes that contain potassium" type="Substance"><Normalization><mmtx cui="C0037494" phraseText="salt" preferredWord="Sodium Chloride" semType="bacs, inch, phsu"/><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="44:56" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.3" text="MICARDIS HCT" type="Drug"><Normalization><mmtx cui="C0939381" phraseText="A patient receiving MICARDIS HCT tablets" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="91:112" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.4" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.4" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.107.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109" lineNumber="105" text="Aliskiren: Do not co-administer aliskiren with MICARDIS HCT in patients with diabetes. " type="regular"><entity charOffset="11:31" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="32:41" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MICARDIS HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="47:59" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.3" text="MICARDIS HCT" type="Drug"><Normalization><mmtx cui="C0939381" phraseText="aliskiren with MICARDIS HCT" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="77:85" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.4" ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.109.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110" lineNumber="105" text="Avoid use of aliskiren with MICARDIS HCT in patients with renal impairment (GFR 60 mL/min)." type="regular"><entity charOffset="0:5" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="28:40" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.2" text="MICARDIS HCT" type="Drug"><Normalization><mmtx cui="C0939381" phraseText="with MICARDIS HCT" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="58:74" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.3" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.3" ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.110.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111" lineNumber="106" text="Digoxin : When telmisartan was co-administered with digoxin, median increases in digoxin peak plasma concentration (49%) and in trough concentration (20%) were observed. " type="regular"><entity charOffset="68:80|89:114" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.1" text="increases in peak plasma concentration" type="Increase_Interaction"/><entity charOffset="81:88" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="median increases in digoxin peak plasma concentration" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="median increases in digoxin peak plasma concentration" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="15:26" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.3" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="68:80|128:148" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.5" text="increases in trough concentration" type="Increase_Interaction"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.5"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.111.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112" lineNumber="106" text="It is, therefore, recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing telmisartan to avoid possible over- or under-digitalization." type="regular"><entity charOffset="53:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.1" text="monitored" type="Caution_Interaction"/><entity charOffset="109:120" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="discontinuing telmisartan to" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="35:42" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="that digoxin levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.112.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113" lineNumber="107" text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors. " type="regular"><entity charOffset="21:39|48:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.1" text="increases in serum concentrations" type="Increase_Interaction"/><entity charOffset="40:47" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Reversible increases in serum lithium concentrations" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="145:185" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.3" text="angiotensin converting enzyme inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with angiotensin converting enzyme inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="67:75" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="21:39|48:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.6" text="increases in serum concentrations" type="SPAN"/><entity charOffset="67:75" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.7" text="toxicity" type="SPAN"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.5"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114" lineNumber="107" text="Cases have also been reported with angiotensin II receptor antagonists including telmisartan. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113" Text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors. "/><anaphoraEntity charOffset="0:5" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.4" text="Cases" type="Expression"/><antecedentEntity charOffset="21:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.1" text="increases in serum concentrations" type="Increase_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113" Text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors. "/><anaphoraEntity charOffset="0:5" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.4" text="Cases" type="Expression"/><antecedentEntity charOffset="21:62" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.6" text="increases in serum concentrations" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113" Text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors. "/><anaphoraEntity charOffset="0:5" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.4" text="Cases" type="Expression"/><antecedentEntity charOffset="67:75" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.5" text="toxicity" type="Increase_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113" Text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors. "/><anaphoraEntity charOffset="0:5" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.4" text="Cases" type="Expression"/><antecedentEntity charOffset="67:75" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.7" text="toxicity" type="SPAN"/></anaphoraRelation><entity charOffset="0:5" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.1" text="Cases" type="Increase_Interaction"/><entity charOffset="35:70" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.2" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="reported with angiotensin II receptor antagonists" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="81:92" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.7" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan." preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugClassMembership drug="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.7" drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.2"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113" text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors. "><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.113.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.114.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115" lineNumber="107" text="Because lithium should not be used with diuretics, the use of lithium with telmisartan and hydrochlorothiazide is not recommended." type="regular"><entity charOffset="23:34" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.1" text="not be used" type="Caution_Interaction"/><entity charOffset="40:49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.2" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="used with diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="8:15" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="114:129" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.5" text="not recommended" type="Caution_Interaction"/><entity charOffset="62:69" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the use of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="75:110" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.7" text="telmisartan and hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="with telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.6" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.7" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.115.e.5" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116" lineNumber="108" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) : In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including telmisartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="249:255" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="267:293" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="300:335" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.4" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="347:358" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.5" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan," preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="374:405" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="128:135" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.8" text="elderly" type="SPAN"/><entity charOffset="137:152" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.9" text="volume-depleted" type="SPAN"/><entity charOffset="200:226" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.10" text="compromised renal function" type="SPAN"/><entity charOffset="426:445" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.2"/><drugClassMembership drug="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.5" drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.4"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.7"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.8"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.9"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.12"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.8"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.9"/></relation><relation type="hasContext"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.8, Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.9, Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.10" ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.4" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.116.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118" lineNumber="108" text="Monitor renal function periodically in patients receiving telmisartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="74:79" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.2" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="58:69" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.3" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.118.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119" lineNumber="109" text="The antihypertensive effect of angiotensin II receptor antagonists, including telmisartan may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="111:117" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="128:154" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.5" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.7" text="antihypertensive effect" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.2" drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.1"/><classClassMembership drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.5"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.7"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.4" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.119.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120" lineNumber="110" text="Ramipril and Ramiprilat : Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3 and 2.1 fold, respectively, and Cmax and AUC of ramiprilat 2.4 and 1.5 fold, respectively. " type="regular"><entity charOffset="126:153" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.1" text="increases steady-state Cmax" type="Increase_Interaction"/><entity charOffset="47:58" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0990503" phraseText="Co-administration of telmisartan 80 mg" preferredWord="telmisartan 80 MG" semType="clnd"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="165:173" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.3" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="AUC of ramipril 2.3" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="126:148|158:161" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.5" text="increases steady-state AUC" type="Increase_Interaction"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121" lineNumber="110" text="In contrast, Cmax and AUC of telmisartan decrease by 31% and 16%, respectively. " type="irregular"><entity charOffset="13:17|41:49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.1" text="Cmax decrease" type="Decrease_Interaction"/><entity charOffset="29:40" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="AUC of telmisartan decrease" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="22:25|41:49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.4" text="AUC decrease" type="Decrease_Interaction"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120" text="Ramipril and Ramiprilat : Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3 and 2.1 fold, respectively, and Cmax and AUC of ramiprilat 2.4 and 1.5 fold, respectively. "><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120" text="Ramipril and Ramiprilat : Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3 and 2.1 fold, respectively, and Cmax and AUC of ramiprilat 2.4 and 1.5 fold, respectively. "><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.120.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.121.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122" lineNumber="110" text="When co-administering telmisartan and ramipril, the response may be greater because of the possibly additive pharmacodynamic effects of the combined drugs, and also because of the increased exposure to ramipril and ramiprilat in the presence of telmisartan." type="regular"><entity charOffset="100:132" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.1" text="additive pharmacodynamic effects" type="Specific_Interaction"/><entity charOffset="38:46" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.2" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril," preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="22:33" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.3" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="180:198" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.5" text="increased exposure" type="Increase_Interaction"/><entity charOffset="202:210" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.6" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="to ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="245:256" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.7" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="ramiprilat in the presence of telmisartan." preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.5"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.6" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.7" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.122.e.5" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123" lineNumber="111" text="Warfarin : Telmisartan administered for 10 days slightly decreased the mean warfarin trough plasma concentration, this decrease did not result in a change in International Normalized Ratio (INR)." type="regular"><entity charOffset="57:75|85:112" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.1" text="decreased the mean trough plasma concentration" type="Decrease_Interaction"/><entity charOffset="11:22" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.2" text="Telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="Telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="76:84" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.3" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="the mean warfarin trough plasma concentration," preferredWord="Warfarin" semType="phsu, orch, hops"/><mmtx cui="C0043031" phraseText="the mean warfarin trough plasma concentration," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.123.e.1" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124" text="Other Drugs : Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen. " type="negative"><entity charOffset="185:194" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0" text="ibuprofen" type="Biomedical_Entity"><Normalization><mmtx cui="C0020740" phraseText="ibuprofen." preferredWord="Ibuprofen" semType="phsu, orch"/><RxNorm RxCui="5640"/></Normalization></entity><entity charOffset="162:181" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="134:147" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2" text="glibenclamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="glibenclamide," preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="107:120" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3" text="acetaminophen" type="Biomedical_Entity"><Normalization><mmtx cui="C2917659" phraseText="with acetaminophen," preferredWord="Acetaminophen [EPC]" semType="phsu"/><RxNorm RxCui="161"/></Normalization></entity><entity charOffset="122:132" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="35:46" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="Co-administration of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="149:160" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6" text="simvastatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0074554" phraseText="simvastatin," preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.124.e.6"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" lineNumber="115" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="60:83" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.1" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="Potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="6:13" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.2" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="&gt;Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="32:41" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.3" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="15:27" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.4" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.3"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.4"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.4" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129" lineNumber="116" text="&lt;item&gt;Antidiabetic drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="78:95" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="6-37" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="78:95" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="42-49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.4" text="insulin" type="Drug"/></anaphoraRelation><entity charOffset="6:24|26:37" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="&gt;Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="42:49" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="53:70" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.6" text="Dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.6"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur."/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129.e.1"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130" lineNumber="117" text="&lt;item&gt;Other antihypertensive drugs : Additive effect or potentiation." type="irregular"><entity charOffset="37:68" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130.e.1" text="Additive effect or potentiation" type="Increase_Interaction"/><entity charOffset="12:34" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130.e.2" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="Other antihypertensive drugs" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129" text="&lt;item&gt;Antidiabetic drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required."/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131" text="&lt;item&gt;Cholestyramine and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="negative"><entity charOffset="6:20" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.0" text="cholestyramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008402" phraseText="&gt;Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="25:35" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.1" text="colestipol" type="Biomedical_Entity"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="59:78" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.0" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.2"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132" lineNumber="118" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively." type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.1" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.2" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="68:87" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="92:98|103:113" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.4" text="reduce absorption" type="Decrease_Interaction"/><entity charOffset="23:37" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.5" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.6" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.6" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.1" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.4" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.1" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.4" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.5" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132.e.6"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133" lineNumber="119" text="&lt;item&gt;Corticosteroids, ACTH : Intensified electrolyte depletion, particularly hypokalemia." type="irregular"><entity charOffset="42:63" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.1" text="electrolyte depletion" type="Specific_Interaction"/><entity charOffset="23:27" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.2" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><entity charOffset="6:21" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.3" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="&gt;Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.5" text="hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129" text="&lt;item&gt;Antidiabetic drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130" text="&lt;item&gt;Other antihypertensive drugs : Additive effect or potentiation."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131" text="&lt;item&gt;Cholestyramine and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129" text="&lt;item&gt;Antidiabetic drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130" text="&lt;item&gt;Other antihypertensive drugs : Additive effect or potentiation."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131" text="&lt;item&gt;Cholestyramine and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134" lineNumber="120" text="&lt;item&gt;Pressor amines (e.g., norepinephrine) : Possible decreased response to pressor amines but not sufficient to preclude their use." type="irregular"><entity charOffset="6:20" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.1" text="Pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="&gt;Pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="28:42" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.2" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="55:73" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.4" text="decreased response" type="Decrease_Interaction"/><entity charOffset="77:91" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.5" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Possible decreased response to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><drugClassMembership drug="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.2" drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.1"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129" text="&lt;item&gt;Antidiabetic drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130" text="&lt;item&gt;Other antihypertensive drugs : Additive effect or potentiation."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131" text="&lt;item&gt;Cholestyramine and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133" text="&lt;item&gt;Corticosteroids, ACTH : Intensified electrolyte depletion, particularly hypokalemia."/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134.e.5"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135" lineNumber="121" text="&lt;item&gt;Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine) : Possible increased responsiveness to the muscle relaxant." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="113:128" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.4" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="6-48" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.1" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="6:48" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.1" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="&gt;Skeletal muscle relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="56:68" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.2" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="81:105" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.6" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.2" drugClass="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.1"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.6"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.135.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127" text="&lt;main&gt;When administered concurrently, the following drugs may interact with thiazide diuretics:"><entity charOffset="76:94" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.127.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.128" text="&lt;item&gt;Alcohol, barbiturates, or narcotics : Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.129" text="&lt;item&gt;Antidiabetic drugs (oral agents and insulin) : Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.130" text="&lt;item&gt;Other antihypertensive drugs : Additive effect or potentiation."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.131" text="&lt;item&gt;Cholestyramine and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.132" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.133" text="&lt;item&gt;Corticosteroids, ACTH : Intensified electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.134" text="&lt;item&gt;Pressor amines (e.g., norepinephrine) : Possible decreased response to pressor amines but not sufficient to preclude their use."/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136" lineNumber="122" text="&lt;item&gt;Lithium : Should not generally be given with diuretics. " type="regular"><entity charOffset="23:45" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.1" text="not generally be given" type="Caution_Interaction"/><entity charOffset="6:13" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.2" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="&gt;Lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="51:60" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.136.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137" lineNumber="122" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="regular"><entity charOffset="16:42" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.1" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="0:15" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.2" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="46:53" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.3" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.6" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.137.e.5" type="Increase_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138" text="Refer to the package insert for lithium preparations before use of such preparations with Micardis HCT (telmisartan and hydrochlorothiazide) tablets." type="negative"><entity charOffset="120:139" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="104:115" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="with Micardis HCT (telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.2" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="90:102" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.3" text="micardis hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939381" phraseText="with Micardis HCT (telmisartan" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.1"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.138.e.3"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139" lineNumber="123" text="&lt;item&gt;Non-steroidal anti-inflammatory drugs : In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. " type="regular"><entity charOffset="130:149|185:192" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.1" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="224:242" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.2" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="88:125" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3" text="non-steroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="202:219|233:242" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.4" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="196:200|233:242" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.5" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="130:140|168:192" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.7" text="reduce the antihypertensive effects" type="Specific_Interaction"/><entity charOffset="130:140|151:162|185:192" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.9" text="reduce the natriuretic effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.ddi.2"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.7"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.ddi.3"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.9"><relations><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.4" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.5" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.139.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140" lineNumber="123" text="Therefore, when MICARDIS HCT tablets and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="126:134" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.1" text="observed" type="Caution_Interaction"/><entity charOffset="41:79" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.2" text="non-steroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="non-steroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="16:28" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.3" text="MICARDIS HCT" type="Drug"><Normalization><mmtx cui="C0939381" phraseText="MICARDIS HCT tablets" preferredWord="Micardis-HCT" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><drugInteraction id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.ddi.1"><interaction trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.3" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.2" trigger="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.140.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.142" text="No carcinogenicity, mutagenicity, or fertility studies have been conducted with the combination of telmisartan and hydrochlorothiazide." type="negative"><entity charOffset="115:134" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.142.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="99:110" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.142.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="conducted with the combination of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.142.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.142.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.145" text="The highest doses administered to mice (1000 mg/kg/day) and rats (100 mg/kg/day) are, on a mg/m2 basis, about 59 and 13 times, respectively, the maximum recommended human dose (MRHD) of telmisartan. " type="negative"><entity charOffset="186:197" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.145.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="of telmisartan." preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="97:102" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.145.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.145.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.145.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.149" text="No drug-related effects on the reproductive performance of male and female rats were noted at 100 mg/kg/day (the highest dose administered), about 13 times, on a mg/m2 basis, the MRHD of telmisartan. " type="negative"><entity charOffset="187:198" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.149.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="the MRHD of telmisartan." preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="168:173" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.149.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.149.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.149.e.0"/></sentence><sentence id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158" text="It is not known whether telmisartan is excreted in human milk, but telmisartan was shown to be present in the milk of lactating rats. " type="negative"><entity charOffset="118:127" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.0" text="lactating" type="Biomedical_Entity"><Normalization><mmtx cui="C0376261" phraseText="present in the milk of lactating rats." preferredWord="Lactate" semType="phsu, orch"/><RxNorm RxCui="114202"/></Normalization></entity><entity charOffset="67:78" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="24:35" id="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.2" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.1" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.0"/><pair ddi="false" e1="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.2" e2="Dailymed.b078dae2-664d-4144-847a-3b9d9b557402.s.158.e.0"/></sentence><positiveExamples number="39"/><negativeExamples number="97"/></document>